Takashi Shibutani

Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer

Kazuhiro Suzuki, Shoji Nagao, Takashi Shibutani et al. · Gynecologic Oncology · 2019 · 36 citations

Cervical Cancer, Phase Ii Trial, Medicine +7

Association between financial toxicity and health-related quality of life of patients with gynecologic cancer

Yusuke Kajimoto, Kazunori Honda, Shiro Suzuki et al. · International Journal of Clinical Oncology · 2023 · 21 citations

Quality Of Life, Life Assessment, Financial Toxicity +12

Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer

Yusuke Kajimoto, Takashi Shibutani, Shoji Nagao et al. · International Journal of Gynecological Cancer · 2022 · 13 citations

Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study

Takashi Shibutani, Shoji Nagao, Kazuhiro Suzuki et al. · International Journal of Clinical Oncology · 2019 · 11 citations

Neoadjuvant Chemotherapy, Conventional Paclitaxel, Medicine +8

Effect of prior olaparib maintenance therapy for platinum sensitive recurrent ovarian cancer on response to subsequent platinum‐based chemotherapy

Hiroshi Nakazawa, Shoji Nagao, Moyu Narita et al. · Journal of obstetrics and gynaecology research · 2022 · 11 citations